ROIV

Roivant Sciences
ROIV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$8.06B
EV
$3.36B
Shares Outstanding
756.02M
Beta
1.25

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$16.75
P/E 2025E
-
P/Revenue 2025E
57.01x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Roivant Sciences Ltd.

gainify
ROIV

Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies fo...

Sector

Healthcare

Industry

Biotechnology

CEO

Gline, Matthew

Employees

908

IPO Date

2020-12-08

Headquarters

50 Broadway, 7th Floor, London, Greater London, SW1H 0DB, United Kingdom

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved